Drreddys Laboratories | RDY - 負債





負債 変化する 日付
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Bayer EUR 39.39B 1.31B 2025-03
Canopy Growth CAD 259.33M 68.47M 2025-09
Cipla INR 4.38B 231.9M 2025-03
Corcept Therapeutics USD 6.36M 247K 2025-09
Drreddys Laboratories INR 67.73B 19.09B 2025-12
GlaxoSmithKline GBP 17.75B 396M 2025-09
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Lonza CHF 4.71B 915M 2024-12
Novartis USD 32.64B 1.37B 2025-06
Pacira USD 372.19M 4.53M 2025-12
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.04B 1.7M 2025-09
Richter Gedeon HUF 21.74B 1.93B 2024-12
Sun Pharmaceuticals INR 23.62B 2.1B 2025-03
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09